A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.

Condition:   Anemia of Chronic Kidney Disease Interventions:   Drug: JTZ-951;   Drug: Darbepoetin Alfa Sponsor:   JW Pharmaceutical Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials